Ligand Pharmaceuticals (LGND) EBT Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67% |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn | -34.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.57% |
| Dec 31, 2025 | 32.99% |
| Sep 30, 2025 | 125.22% |
| Jun 30, 2025 | 9.02% |
| Mar 31, 2025 | -76.39% |
| Dec 31, 2024 | -61.24% |
| Sep 30, 2024 | -34.17% |
| Jun 30, 2024 | -58.26% |
| Mar 31, 2024 | 170.00% |
| Dec 31, 2023 | 4.00% |
| Sep 30, 2023 | -1.50% |
| Jun 30, 2023 | -51.69% |
| Mar 31, 2023 | 56.40% |
| Dec 31, 2022 | 70.46% |
| Sep 30, 2022 | 37.89% |
| Jun 30, 2022 | 35.37% |
| Mar 31, 2022 | -26.22% |
| Dec 31, 2021 | 32.28% |
| Sep 30, 2021 | -42.25% |
| Jun 30, 2021 | -29.63% |
| Mar 31, 2021 | -52.94% |
| Dec 31, 2020 | -20.86% |
| Sep 30, 2020 | -43.61% |
| Jun 30, 2020 | 50.19% |
| Mar 31, 2020 | -90.48% |
| Dec 31, 2019 | -46.29% |
| Sep 30, 2019 | -164.04% |
| Jun 30, 2019 | -21.50% |
| Mar 31, 2019 | 344.88% |
| Dec 31, 2018 | -127.30% |
| Sep 30, 2018 | 121.56% |
| Jun 30, 2018 | 62.46% |
| Mar 31, 2018 | 808.34% |
| Dec 31, 2017 | 63.54% |
| Sep 30, 2017 | 137.51% |
| Jun 30, 2017 | 88.41% |
| Mar 31, 2017 | 42.28% |
| Dec 31, 2016 | 53.31% |
| Sep 30, 2016 | -15.75% |
| Jun 30, 2016 | -66.82% |
| Mar 31, 2016 | 91.17% |
| Dec 31, 2015 | 83.06% |
| Sep 30, 2015 | 421.80% |
| Jun 30, 2015 | 96.50% |
| Mar 31, 2015 | 54.25% |
| Dec 31, 2014 | 12.02% |
| Sep 30, 2014 | 30.39% |
| Jun 30, 2014 | 53.34% |
| Mar 31, 2014 | 36.14% |
| Dec 31, 2013 | 48.34% |
| Sep 30, 2013 | 29.61% |
| Jun 30, 2013 | 124.77% |